Generic drugs undergo clinical testing for side effects
Generic drugs undergo rigorous bioequivalence and clinical testing that routinely include monitoring for side effects and adverse events.
The claim is a specific, verifiable empirical statement about the regulatory and clinical testing of generic pharmaceuticals. Multiple peer-reviewed studies (Papers 1, 2, 4, 5, and 7) explicitly detail how bioequivalence and clinical evaluation trials monitor, record, and assess adverse events and tolerability for generic formulations. There are no refuting papers.
Kotadia R, Kumar S, Khuroo A, Dharmadhikari S, Shahi P, Narayana GNVSS, Reyar S. Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions.. 2026. https://doi.org/10.1002/cpdd.70076
Evaluates generic relugolix/estradiol/norethindrone acetate and monitors adverse events during bioequivalence testing.
See more details
Sharma JK, Bunger D, Zaveri H, Chaturvedi A. Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects.. 2026. https://doi.org/10.3389/fneph.2026.1838510
Assesses safety, tolerability, and adverse events for generic tacrolimus extended-release tablets.
Yan H, Zhou M, Pan Z, Peng Y, Wang J, Li X, Xie Y, Liu Q, Huang C, Wang Q, Liu G. Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Conditions.. 2026. https://doi.org/10.1007/s40268-026-00541-0
Monitors adverse events and tolerability for a generic piracetam tablet compared to a reference product.
Rezk MR, Badr KA, Hosny AAEH, Abdel Magid AM. Bioequivalence evaluation of two cariprazine hard capsule formulations.. 2026. https://doi.org/10.1007/s00210-026-05017-1
Assesses the safety profile and adverse events of a generic cariprazine formulation.
Ferchichi K, Gaies E, Ben Hammamia S, El Jebari H, Daldoul M, Ghorbel S, Srairi S, Guermazi S, Gorgi Y, Boutiba I, Bouzid K, Abbessi A, Daghfous R, Ben Sassi M, Trabelsi S. Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions.. 2026. https://doi.org/10.1038/s41598-025-34082-4
Monitors adverse events during bioequivalence and clinical testing of a generic metformin/vildagliptin combination.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt